08/03/2021 · IDG Capital has backed some of China’s hottest startups. The venture capital and private equity firm that got its start in China in 1993 has made more than 1,000 investments over the past two decades. It made early bets on the Chinese search engine giant Baidu and the powerhouse social networking and gaming giant Tencent but has also backed ...

IDG Capital. 30,527 followers. 5mo. Report this post. IDG Capital has led a $120 million Series D round in SaaS-based business service platform Xiaoetong. Founded …

12月16日，idg资本在2020年的第11家上市企业——恒玄科技（bes）正式登陆科创板，此次发行价为162.07元，开盘价391元，涨幅一度超过130%，市值超450亿。 idg资本是恒玄科技的创始投资人。从2016年开始，在恒玄科技仅有的三轮融资中，idg资本均有参与，陪伴着恒玄科技的从0到1，是恒玄科技最大外部股东。

ZhenGe Biotechnology, a Shanghai-based contract development and manufacturing organization firm, has completed a Series C financing round of $100 …

idg资本于1993年起率先在中国开展风险投资业务。多年来，idg资本始终追求长期价值投资，与来自世界各地多样化的投资伙伴保持长期亲密的合作关系。 idg资本在风险投资、私募股权和收购兼并领域均积累了丰富的投资经验。

Lyvgen Biopharma, a biotech company focused on developing innovative immuno-oncology therapeutics, announces that it has completed Series C founding. This round of financing was led by IDG Capital and included Shanghai FTZ Fund, Suzhou Longmen Venture Capital, CHENGWEI Capital and others, with China Renaissance Group as the exclusive financial adviser.

Since its inception, IDG Capital has expanded into 15 cities around the world, including New York, Boston, London, Beijing, Shanghai, Hong Kong, Seoul and Hanoi. Accumulated assets under management have grown from $10 million in 1992 to approximately $20 billion today.